NOVONIX Limited announced the future appointment of Andrew N. Liveris AO to its board of directors as further step in the company's downstream integration strategy and plans. The appointment will be made following Liveris' transition from his roles with Dow and DowDuPont in 2018. Mr. Liveris is currently the Executive Chairman of DowDuPont. Mr. Liveris also serves as Chief Executive Officer of The Dow Chemical Company. His prospective appointment to the board of the company follows the recent appointment of Admiral Robert J. Natter to the Board, along with the acceleration of the company's downstream integration strategy and plans.